Douglas E. Williams

2012 - Biogen

In 2012, Douglas E. Williams earned a total compensation of $4M as EVP, Research Development at Biogen, a 17% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$698,544
Salary$657,865
Stock Awards$2,486,226
Other$121,023
Total$3,963,658

Williams received $2.5M in stock awards, accounting for 63% of the total pay in 2012.

Williams also received $698.5K in non-equity incentive plan, $657.9K in salary and $121K in other compensation.

Rankings

In 2012, Douglas E. Williams' compensation ranked 1,663rd out of 11,487 executives tracked by ExecPay. In other words, Williams earned more than 85.5% of executives.

ClassificationRankingPercentile
All
1,663
out of 11,487
86th
Division
Manufacturing
594
out of 4,253
86th
Major group
Chemicals And Allied Products
134
out of 1,203
89th
Industry group
Drugs
72
out of 925
92nd
Industry
Biological Products, Except Diagnostic Substances
11
out of 165
93rd
Source: SEC filing on April 30, 2014.

Williams' colleagues

We found four more compensation records of executives who worked with Douglas E. Williams at Biogen in 2012.

2012

George Scangos

Biogen

Chief Executive Officer

2012

John Cox

Biogen

EVP, Pharmaceutical Operations Technology

2012

Paul Clancy

Biogen

Chief Financial Officer

2012

Kenneth DiPietro

Biogen

EVP, Human Resources

News

You may also like